We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Scientists are trying to understand the cause of neurological effects and whether symptoms will be long-lasting
Plea comes as continent’s top vaccine production plant faces uncertain future due to collapse in demand
China’s strict policy puts citizens at mercy of unpredictable isolation orders as security camps outside
The president announced the move at a virtual summit hosted by the US, Belize, Germany, Indonesia and Senegal
Isolated country has not vaccinated population, stoking worries about potential damage of outbreak
Japanese people consume about twice the amount of salt recommended. Could a new gadget one day help?
Lockdowns, adenoviruses, Covid and exposure to dogs have all been blamed for new cases around the world
New modelling underscores country’s vulnerability because of faltering vaccination drive
German biotech maintains guidance but prepares for fall in sales because of jab oversupply
Health body says 15mn people died by the end of 2021, nearly three times official death toll
Pyongyang claims to have avoided a big outbreak but experts warn its luck will eventually run out
US drugmaker says demand for ‘bivalent booster’ could lift jab sales in second half of 2022
Vulnerable people feel they are forgotten because of government’s ‘living with Covid’ strategy
The supposedly magic fix of solar geoengineering may have a dangerously uneven impact across the world
The philanthropist urges world leaders to increase spending to improve preparedness for health threats
The problems threaten plans to produce 60 per cent of all vaccines administered in Africa locally by 2040
Revenue rises 60% as Alexion acquisition and its rare diseases medicines boost drugmaker’s earnings
Experts are racing to find the cause of an unexplained illness diagnosed in nearly 200 youngsters
Hotspots for viral transmission among animals are projected to overlap with densely populated urban areas
The FT’s third annual ranking of the region’s businesses by revenue growth rate. Plus: US medtech takes the top spot; Calgary tech scene rivals energy sector; ecommerce giant aims to ‘democratise finance’; why LatAm risks squandering pandemic gains
The medtech muscles in on overactive bladder market with its neuro-stimulator treatment device
Could politicians have responded better to Covid? Public health expert Devi Sridhar is both prescient and scathing
Two top-10 shareholders say distribution problems not supply is reason for slower vaccination rates in low-income countries
Discharging hospital patients into population of vulnerable elderly without testing was ‘irrational’, say judges
UK drugmaker points to ‘good momentum’ as sales rise by a third in ‘landmark year’
International Edition
